Pfizer's 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low

ToplinePfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the American pharmaceutical giant attempts to regain its footing as the COVID-19 pandemic subsides. Pfizer CEO Albert Bourla is navigating his company through a trying time.POOL/AFP via Getty Images Key FactsPfizer’s $0.55 diluted earnings per share and $14.9 billion in first-quarter sales smashed respective forecasts of $0.51 and $13.87 billion, according to average analyst estimates. With Pfizer’s top line ...